JP Stock MarketDetailed Quotes

4569 Kyorin Pharmaceutical

Watchlist
  • 1505
  • +19+1.28%
20min DelayMarket Closed Dec 30 15:30 JST
97.23BMarket Cap16.23P/E (Static)

About Kyorin Pharmaceutical Company

Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Company Profile

Symbol4569
Company NameKyorin Pharmaceutical
Founded1958-10-31
MarketTSE Prime
Employees2048
Fiscal Year Ends03-31
Address6, Kanda Surugadai 4-chome Chiyoda-ku
Zip Code100-0004
Phone03-6374-9700

Company Executives

  • Name
  • Position
  • Salary
  • Yutaka Ogihara
  • Director, President and Chief Executive Officer
  • --
  • Yasuji Kurose
  • Corporate Officer, Director, Chief Financial Officer, Director of Corporate Planning and CSto
  • --
  • Michiro Onota
  • Director and Chief Marketing Officer
  • --
  • Noriyuki Shikanai
  • Independent Director
  • --
  • Ken Shigematsu
  • Independent Director
  • --
  • Hiromi Watanabe
  • Independent Director
  • --